ArticleHaematologica2022

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma.

Cyril Quivoron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.